Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

PI3K/Akt Inhibitor Library: FAQs & Key Facts

PI3K/Akt Inhibitor Library is a curated collection of bioactive small molecules targeting key nodes of the phosphoinositide 3-kinase/Akt signalling axis, designed to accelerate high-throughput screening and mechanistic research in oncology and related disease areas.

Aladdin SKU
Lib412036
Selleck Reference Number
L2800
Primary Targets
PI3K isoforms (α, β, γ, δ), Akt (PKB) isoforms, and related pathway components (e.g., mTOR, PDK1, PTEN)
Primary Application
High-throughput and phenotypic screening, pathway dissection, cancer biology research
Format
Pre-plated or bulk small-molecule compounds supplied as DMSO solutions or dry powder (confirm format at ordering)

What Is the PI3K/Akt Inhibitor Library?

The PI3K/Akt Inhibitor Library (Lib412036) is a focused collection of pharmacologically validated small-molecule inhibitors that target the phosphoinositide 3-kinase (PI3K)/Akt signalling pathway. This pathway is one of the most frequently dysregulated cascades in human cancer and metabolic disease, making pathway-specific inhibitor libraries an essential resource for drug discovery and basic research.

The library covers multiple nodes of the PI3K/Akt axis, including class I PI3K isoforms (PI3Kα, PI3Kβ, PI3Kγ, PI3Kδ), Akt isoforms 1–3, and closely associated downstream and upstream regulators such as mTOR, PDK1, and PTEN. Each compound in the library has documented in vitro activity and selectivity data, enabling researchers to interrogate specific pathway nodes and distinguish isoform-selective effects from pan-PI3K inhibition.

This product is listed under Selleck reference number L2800 and is available through Aladdin Scientific as catalog number Lib412036.

Biological Targets and Pathway Coverage

The PI3K/Akt pathway transmits growth factor and receptor tyrosine kinase signals to regulate cell survival, proliferation, metabolism, and motility. When activated, PI3K phosphorylates phosphatidylinositol-4,5-bisphosphate (PIP2) to generate phosphatidylinositol-3,4,5-trisphosphate (PIP3), which recruits and activates Akt (also known as protein kinase B, PKB). Akt then phosphorylates a broad set of substrates controlling apoptosis, cell-cycle progression, and protein synthesis, partly through mTOR complex 1 (mTORC1).

The PI3K/Akt Inhibitor Library provides inhibitors for all major druggable nodes along this cascade:

  • Class I PI3K inhibitors — pan-PI3K and isoform-selective compounds (α-, β-, γ-, δ-selective)
  • Akt inhibitors — ATP-competitive and allosteric inhibitors of Akt1, Akt2, and Akt3
  • PDK1 inhibitors — blocking the kinase that phosphorylates Akt at Thr308
  • mTOR inhibitors — rapalogs and catalytic mTOR inhibitors (mTORC1/2 dual)
  • PTEN modulators — compounds affecting the main negative regulator of PIP3 levels
  • Dual PI3K/mTOR inhibitors — single agents that suppress both enzymes simultaneously

This breadth of coverage enables systematic dissection of signalling hierarchy and cross-talk within the PI3K/Akt network.

Applications and Experimental Use

The PI3K/Akt Inhibitor Library is designed to support a wide range of research workflows:

  • High-throughput screening (HTS) — The pre-formatted compound collection enables rapid phenotypic or target-based screens in cell-based assay platforms, including 96-well and 384-well formats.
  • Pathway mechanistic studies — Researchers can use selective inhibitors from the library to map epistatic relationships and identify rate-limiting steps within the PI3K/Akt/mTOR cascade.
  • Drug combination studies — The library facilitates systematic combination-testing with chemotherapeutics, receptor-targeted agents, or other pathway inhibitors to identify synergistic or antagonistic interactions.
  • Resistance mechanism research — Screening cancer cell lines with acquired resistance against individual inhibitors in the library can reveal bypass mechanisms and alternative therapeutic vulnerabilities.
  • Biomarker discovery — Differential sensitivity profiles across cell lines or patient-derived models can help identify predictive biomarkers for PI3K pathway-targeted therapies.

All compounds should be validated in the researcher's specific cell or biochemical system prior to large-scale use. Positive and negative controls appropriate to the assay format are strongly recommended.

Storage, Handling, and Quality

Proper storage and handling are essential to preserve the activity of compounds in the PI3K/Akt Inhibitor Library. General best-practice guidelines for small-molecule inhibitor libraries are provided below; always consult the product-specific documentation supplied with your order for definitive conditions.

  • Storage temperature — Most kinase inhibitor libraries are stored at −20 °C (dry powder) or −80 °C (DMSO stock solutions). Confirm the recommended condition from the Certificate of Analysis (CoA) or product datasheet.
  • Avoid freeze-thaw cycles — Repeated freeze-thaw cycles can degrade compound integrity and reduce potency. Prepare single-use aliquots where possible.
  • DMSO solubility — Compounds are typically supplied as 10 mM stock solutions in DMSO. Ensure DMSO concentration in assay media does not exceed 0.1–0.5% to minimise cytotoxic effects on target cells.
  • Light sensitivity — Some compounds may be light-sensitive; store in amber tubes or foil-wrapped containers where indicated.
  • Purity — Compounds in Selleck-sourced libraries are typically ≥98% pure by HPLC; verify purity documentation in the accompanying CoA.

Contact Aladdin Scientific technical support for compound-specific solubility data, formulation advice, or replacement compound requests.

Ordering and Customisation

The PI3K/Akt Inhibitor Library (Lib412036) can be ordered directly through Aladdin Scientific. The following information is relevant for procurement and lab managers:

  • Catalog number — Lib412036 (Aladdin Scientific); Selleck reference L2800.
  • Available formats — Contact Aladdin to confirm current available formats, including pre-plated (96- or 384-well plates), tube sets, or bulk powder, as options may vary.
  • Quantity and concentration — Standard and custom quantities and concentrations may be available; discuss requirements with an Aladdin sales representative.
  • Custom sub-libraries — If a subset of PI3K/Akt pathway compounds is required (e.g., only PI3Kδ-selective inhibitors), custom library configurations may be possible; contact Aladdin Scientific for feasibility and pricing.
  • Lead time — Lead times vary by format and stock availability. Contact Aladdin Scientific for current availability and estimated delivery times.
  • Documentation — A Certificate of Analysis, compound list with structures and biological activity data, and MSDS/SDS sheets are typically provided with the library.

For quotation requests, volume pricing, or technical pre-sales questions, contact Aladdin Scientific directly via the website or email.

Frequently asked questions

What targets does the PI3K/Akt Inhibitor Library cover?

The library contains inhibitors targeting multiple nodes of the PI3K/Akt signalling pathway, including class I PI3K isoforms (α, β, γ, δ), Akt isoforms 1–3, PDK1, mTOR (mTORC1 and mTORC2), dual PI3K/mTOR inhibitors, and PTEN modulators. This broad coverage supports systematic interrogation of the entire cascade.

How should the PI3K/Akt Inhibitor Library compounds be stored?

As a general guideline, dry powder compounds should be stored at −20 °C and DMSO stock solutions at −80 °C, protected from light. Avoid repeated freeze-thaw cycles by preparing single-use aliquots. Always refer to the Certificate of Analysis or product datasheet supplied with your specific order for definitive storage conditions.

Can I order a custom subset of the PI3K/Akt Inhibitor Library?

Custom sub-library configurations may be available, allowing you to select compounds based on specific isoform selectivity or pathway node of interest (for example, only PI3Kδ-selective inhibitors). Contact Aladdin Scientific directly to discuss your requirements, feasibility, and pricing.

What is the purity of compounds in the library and what documentation is provided?

Compounds sourced from Selleck-based libraries are typically ≥98% pure as determined by HPLC. Each library order is generally accompanied by a Certificate of Analysis, a compound list with structures and biological activity data, and safety data sheets (SDS/MSDS). Verify purity details in the CoA supplied with your specific order.

What DMSO concentration is safe to use in cell-based assays with these inhibitors?

Compounds are typically supplied as 10 mM stock solutions in DMSO. When diluting into aqueous assay media, the final DMSO concentration should generally not exceed 0.1–0.5% to minimise solvent cytotoxicity. Always run a DMSO-only vehicle control at the same concentration used in compound-treated wells.

References

  1. Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K pathway in human disease. Cell. 2017;170(4):605-635. doi:10.1016/j.cell.2017.07.029
  2. Manning BD, Toker A. AKT/PKB signaling: navigating the network. Cell. 2017;169(3):381-405. doi:10.1016/j.cell.2017.04.001
  3. Saxton RA, Sabatini DM. mTOR signaling in growth, metabolism, and disease. Cell. 2017;168(6):960-976. doi:10.1016/j.cell.2017.02.004

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Categories: Technical Articles: Reagent Chemistry, Synthesis & Bioscience Guides

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.

Cite this article

Aladdin Scientific. "PI3K/Akt Inhibitor Library: FAQs & Key Facts" Aladdin Knowledge Base, updated 19 nov 2026. https://www.aladdinsci.com/eu_it/faqs/pi3k-akt-inhibitor-library-faqs-en.html
Was this article helpful? Yes No 0 out of found this helpful

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.